Négrier, S., Pérol, D., Bahleda, R., Hollebecque, A., Chatelut, E., Boyle, H., . . . Escudier, B. (2017). Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors. BMC Cancer.
Style de citation ChicagoNégrier, Sylvie, et al. "Phase I Dose-escalation Study of Pazopanib Combined With Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Other Advanced Tumors." BMC Cancer 2017.
Style de citation MLANégrier, Sylvie, et al. "Phase I Dose-escalation Study of Pazopanib Combined With Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Other Advanced Tumors." BMC Cancer 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.